Exact Mass: 519.1278

Exact Mass Matches: 519.1278

Found 60 metabolites which its exact mass value is equals to given mass value 519.1278, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Pelargonidin 3-(6'-malonylglucoside)

3-{[(2S,3R,4S,5S,6R)-6-{[(2-carboxyacetyl)oxy]methyl}-3,4,5-trihydroxyoxan-2-yl]oxy}-5,7-dihydroxy-2-(4-hydroxyphenyl)-1lambda4-chromen-1-ylium

C24H23O13+ (519.1139)


Pelargonidin 3-(6-malonylglucoside) is a member of the class of compounds known as anthocyanidin-3-o-glycosides. Anthocyanidin-3-o-glycosides are phenolic compounds containing one anthocyanidin moiety which is O-glycosidically linked to a carbohydrate moiety at the C3-position. Pelargonidin 3-(6-malonylglucoside) is practically insoluble (in water) and a weakly acidic compound (based on its pKa). Pelargonidin 3-(6-malonylglucoside) can be found in cloudberry, lupine, red raspberry, and strawberry, which makes pelargonidin 3-(6-malonylglucoside) a potential biomarker for the consumption of these food products.

   

Ceforanide

(6R,7R)-7-{2-[2-(aminomethyl)phenyl]acetamido}-3-({[1-(carboxymethyl)-1H-1,2,3,4-tetrazol-5-yl]sulfanyl}methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C20H21N7O6S2 (519.0995)


Ceforanide is a second-generation parenteral cephalosporin antibiotic. It has a longer elimination half-life than any currently available cephalosporin. Its activity is very similar to that of cefamandole, a second-generation cephalosporin, except that ceforanide is less active against most gram-positive organisms. Many coliforms, including Escherichia coli, Klebsiella, Enterobacter, and Proteus, are susceptible to ceforanide, as are most strains of Salmonella, Shigella, Hemophilus, Citrobacter and Arizona species. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DC - Second-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

   

Tenofovir disoproxil

Tenofovir disoproxil

C19H30N5O10P (519.173)


J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AF - Nucleoside and nucleotide reverse transcriptase inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D018894 - Reverse Transcriptase Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

Gravacridonetriol glucoside

2-(1,2-dihydroxy-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}propan-2-yl)-5-hydroxy-11-methyl-1H,2H,6H,11H-furo[2,3-c]acridin-6-one

C25H29NO11 (519.1741)


Gravacridonetriol glucoside is found in herbs and spices. Gravacridonetriol glucoside is an alkaloid from Ruta graveolens (rue

   

Dabrafenib

N-{3-[5-(2-aminopyrimidin-4-yl)-2-tert-butyl-1,3-thiazol-4-yl]-2-fluorophenyl}-2,6-difluorobenzene-1-sulfonamide

C23H20F3N5O2S2 (519.101)


L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EC - B-raf serine-threonine kinase (braf) inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2336 - Raf Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors D000970 - Antineoplastic Agents Dabrafenib (GSK2118436A) is an ATP-competitive inhibitor of Raf with IC50s of 5 nM and 0.6 nM for C-Raf and B-RafV600E, respectively[4].

   

Estramustine phosphate

[(5-{[bis(2-chloroethyl)carbamoyl]oxy}-15-methyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-2(7),3,5-trien-14-yl)oxy]phosphonic acid

C23H32Cl2NO6P (519.1344)


   

Tenofovir disoproxil

Bis({[(propan-2-yloxy)carbonyl]oxy}methyl) {[1-(6-amino-9H-purin-9-yl)propan-2-yl]oxy}methanephosphonic acid

C19H30N5O10P (519.173)


   
   
   

Pelargonidin 3-(6-malonylglucoside)

3- [ [ 6-O- (1,3-Dioxo-3-hydroxypropyl) -beta-D-glucopyranosyl ] oxy ] -4,5,7-trihydroxyflavylium

C24H23O13 (519.1139)


   
   

Dabrafenib

Dabrafenib

C23H20F3N5O2S2 (519.101)


L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EC - B-raf serine-threonine kinase (braf) inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2336 - Raf Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors D000970 - Antineoplastic Agents Dabrafenib (GSK2118436A) is an ATP-competitive inhibitor of Raf with IC50s of 5 nM and 0.6 nM for C-Raf and B-RafV600E, respectively[4].

   
   
   

Pelargonidin-3-(6-malonylglucoside)

Pelargonidin-3-(6-malonylglucoside)

[C24H23O13]+ (519.1139)


   

C26H30ClNO8_2-{7-Acetoxy-5-chloro-3-[(1E,3E)-3,5-dimethyl-1,3-heptadien-1-yl]-7-methyl-6,8-dioxo-7,8-dihydro-2(6H)-isoquinolinyl}pentanedioic acid

NCGC00380203-01_C26H30ClNO8_2-{7-Acetoxy-5-chloro-3-[(1E,3E)-3,5-dimethyl-1,3-heptadien-1-yl]-7-methyl-6,8-dioxo-7,8-dihydro-2(6H)-isoquinolinyl}pentanedioic acid

C26H30ClNO8 (519.166)


   

Gravacridonetriol glucoside

2-(1,2-dihydroxy-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}propan-2-yl)-5-hydroxy-11-methyl-1H,2H,6H,11H-furo[2,3-c]acridin-6-one

C25H29NO11 (519.1741)


   
   

Suproclone

Suproclone

C22H22ClN5O4S2 (519.0802)


C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic

   
   

Ipragliflozin L-Proline

Ipragliflozin L-Proline

C26H30FNO7S (519.1727)


   

2-(BETA-D-GALACTOSIDOXY)NAPHTHOL AS-LC

2-(BETA-D-GALACTOSIDOXY)NAPHTHOL AS-LC

C25H26ClNO9 (519.1296)


   

Amrubicin hydrochloride

Amrubicin hydrochloride

C25H26ClNO9 (519.1296)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D000970 - Antineoplastic Agents

   

1H-Azepine,1-[[4-[[4-(2-benzothiazolyl)-1-piperidinyl]sulfonyl]phenyl]sulfonyl]hexahydro-(9CI)

1H-Azepine,1-[[4-[[4-(2-benzothiazolyl)-1-piperidinyl]sulfonyl]phenyl]sulfonyl]hexahydro-(9CI)

C24H29N3O4S3 (519.132)


   

estramustine phosphate

estramustine phosphate

C23H32Cl2NO6P (519.1344)


D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D009588 - Nitrogen Mustard Compounds D009676 - Noxae > D000477 - Alkylating Agents

   

nPOC-POC Tenofovir(Mixture of DiastereoMers)

nPOC-POC Tenofovir(Mixture of DiastereoMers)

C19H30N5O10P (519.173)


   

Tesofensine citrate

Tesofensine citrate

C23H31Cl2NO8 (519.1427)


   
   

(S)-1-((R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy) -2-phenylbut-3- en-2-amine,Maleic acid

(S)-1-((R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy) -2-phenylbut-3- en-2-amine,Maleic acid

C24H23F6NO5 (519.148)


   

sodium dodecyl diphenyl ether disalfonate

sodium dodecyl diphenyl ether disalfonate

C24H32NaO7S2 (519.1487)


   
   

Sulfamic acid, [(1R,2R,3S,4R)-2,3-dihydroxy-4-[[2-[3-[(trifluoromethyl)thio]phenyl]pyrazolo[1,5-a]pyrimidin-7-yl]amino]cyclopentyl]methyl ester

Sulfamic acid, [(1R,2R,3S,4R)-2,3-dihydroxy-4-[[2-[3-[(trifluoromethyl)thio]phenyl]pyrazolo[1,5-a]pyrimidin-7-yl]amino]cyclopentyl]methyl ester

C19H20F3N5O5S2 (519.0858)


C471 - Enzyme Inhibitor

   

12-beta-D-Glucopyranosyl-12,13-dihydro-1,11-dihydroxy-5H-indolo(2,3-a)pyrrolo(3,4-C)carbazole-5,7(6H)-dione

12-beta-D-Glucopyranosyl-12,13-dihydro-1,11-dihydroxy-5H-indolo(2,3-a)pyrrolo(3,4-C)carbazole-5,7(6H)-dione

C26H21N3O9 (519.1278)


   

4-methyl-N-[2-[[2-[(4-methylphenyl)sulfonylamino]phenyl]iminomethyl]phenyl]benzenesulfonamide

4-methyl-N-[2-[[2-[(4-methylphenyl)sulfonylamino]phenyl]iminomethyl]phenyl]benzenesulfonamide

C27H25N3O4S2 (519.1286)


   

Mycobacterium Tuberculosis Inhibitor

Mycobacterium Tuberculosis Inhibitor

C26H21N3O5S2 (519.0923)


   
   

2-Thioxo-4-oxo-5-[3-[(alpha-methylbenzyl)oxy]-4-(phenethyloxy)benzylidene]thiazolidine-3-acetic acid

2-Thioxo-4-oxo-5-[3-[(alpha-methylbenzyl)oxy]-4-(phenethyloxy)benzylidene]thiazolidine-3-acetic acid

C28H25NO5S2 (519.1174)


   

D-cellotrionate

D-cellotrionate

C18H31O17- (519.1561)


   

D-maltotrionate

D-maltotrionate

C18H31O17- (519.1561)


   

(2S)-naringenin 7-O-(6-O-malonyl-beta-D-glucoside)

(2S)-naringenin 7-O-(6-O-malonyl-beta-D-glucoside)

C24H23O13- (519.1139)


   
   

[(1R)-2-(benzenesulfonyl)-1-ethylsulfonyl-7-methoxy-9-methyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]methanol

[(1R)-2-(benzenesulfonyl)-1-ethylsulfonyl-7-methoxy-9-methyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]methanol

C24H29N3O6S2 (519.1498)


   

[(1R)-1-(benzenesulfonyl)-1-(hydroxymethyl)-7-methoxy-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]-(2-pyrazinyl)methanone

[(1R)-1-(benzenesulfonyl)-1-(hydroxymethyl)-7-methoxy-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]-(2-pyrazinyl)methanone

C26H25N5O5S (519.1576)


   

[(1S)-2-(benzenesulfonyl)-1-ethylsulfonyl-7-methoxy-9-methyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]methanol

[(1S)-2-(benzenesulfonyl)-1-ethylsulfonyl-7-methoxy-9-methyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]methanol

C24H29N3O6S2 (519.1498)


   

(6R,7S)-7-[[2-[2-(aminomethyl)phenyl]-1-oxoethyl]amino]-3-[[[1-(carboxymethyl)-5-tetrazolyl]thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

(6R,7S)-7-[[2-[2-(aminomethyl)phenyl]-1-oxoethyl]amino]-3-[[[1-(carboxymethyl)-5-tetrazolyl]thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C20H21N7O6S2 (519.0995)


   
   

3-[2-[(E,3E)-3-(3-ethyl-5-methoxy-1,3-benzothiazol-2-ylidene)-2-methoxyprop-1-enyl]-1,3-benzothiazol-3-ium-3-yl]propane-1-sulfonic acid

3-[2-[(E,3E)-3-(3-ethyl-5-methoxy-1,3-benzothiazol-2-ylidene)-2-methoxyprop-1-enyl]-1,3-benzothiazol-3-ium-3-yl]propane-1-sulfonic acid

C24H27N2O5S3+ (519.1082)


   

Pelargonidin 3-(6-malonylglucoside)

Pelargonidin 3-O-(6-O-malonyl-beta-D-glucoside)

C24H23O13+ (519.1139)


   

Ceforanide

Ceforanide

C20H21N7O6S2 (519.0995)


A second-generation cephalosporin antibiotic with {[1-(carboxymethyl)-1H-tetrazol-5-yl]sulfanyl}methyl and 2-(aminomethyl)phenylacetamido groups at positions 3 and 7, respectively, of the cephem skeleton. It is effective against many coliforms, including Escherichia coli, Klebsiella, Enterobacter and Proteus, and most strains of Salmonella, Shigella, Hemophilus, Citrobacter and Arizona species. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DC - Second-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

   

(2r)-3-[(4a,8,12a,12b-tetrahydroxy-3-methyl-1,7,12-trioxo-5,6-dihydro-4h-tetraphen-6a-yl)sulfanyl]-2-[(1-hydroxyethylidene)amino]propanoic acid

(2r)-3-[(4a,8,12a,12b-tetrahydroxy-3-methyl-1,7,12-trioxo-5,6-dihydro-4h-tetraphen-6a-yl)sulfanyl]-2-[(1-hydroxyethylidene)amino]propanoic acid

C24H25NO10S (519.1199)


   

Aristoloside

aristoloside

C23H21NO13 (519.1013)


{"Ingredient_id": "HBIN016829","Ingredient_name": "Aristoloside","Alias": "aristoloside","Ingredient_formula": "C23H21NO13","Ingredient_Smile": "COC1=CC(=CC2=C3C(=C(C=C12)[N+](=O)[O-])C(=CC4=C3OCO4)C(=O)O)OC5C(C(C(C(O5)CO)O)O)O","Ingredient_weight": "519.41","OB_score": "3.865093461","CAS_id": "84014-70-0","SymMap_id": "SMIT11792","TCMID_id": "1725","TCMSP_id": "MOL010802","TCM_ID_id": "6651","PubChem_id": "128576","DrugBank_id": "NA"}

   

3-{[(2s,3r,4r,5s,6r)-6-{[(2-carboxyacetyl)oxy]methyl}-3,4,5-trihydroxyoxan-2-yl]oxy}-5,7-dihydroxy-2-(4-hydroxyphenyl)-1λ⁴-chromen-1-ylium

3-{[(2s,3r,4r,5s,6r)-6-{[(2-carboxyacetyl)oxy]methyl}-3,4,5-trihydroxyoxan-2-yl]oxy}-5,7-dihydroxy-2-(4-hydroxyphenyl)-1λ⁴-chromen-1-ylium

[C24H23O13]+ (519.1139)


   

(2s)-n-(3-{[2-(2,4-dibromo-5-methoxyphenyl)ethyl](methyl)amino}propyl)-2-(dimethylamino)-4-methylpentanimidic acid

(2s)-n-(3-{[2-(2,4-dibromo-5-methoxyphenyl)ethyl](methyl)amino}propyl)-2-(dimethylamino)-4-methylpentanimidic acid

C21H35Br2N3O2 (519.1096)


   

3-{[(2s,5s)-6-{[(2-carboxyacetyl)oxy]methyl}-3,4,5-trihydroxyoxan-2-yl]oxy}-5,7-dihydroxy-2-(4-hydroxyphenyl)-1λ⁴-chromen-1-ylium

3-{[(2s,5s)-6-{[(2-carboxyacetyl)oxy]methyl}-3,4,5-trihydroxyoxan-2-yl]oxy}-5,7-dihydroxy-2-(4-hydroxyphenyl)-1λ⁴-chromen-1-ylium

[C24H23O13]+ (519.1139)


   

(6r,7r)-7-({2-[2-(aminomethyl)phenyl]-1-hydroxyethylidene}amino)-3-({[1-(carboxymethyl)-1,2,3,4-tetrazol-5-yl]sulfanyl}methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

(6r,7r)-7-({2-[2-(aminomethyl)phenyl]-1-hydroxyethylidene}amino)-3-({[1-(carboxymethyl)-1,2,3,4-tetrazol-5-yl]sulfanyl}methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C20H21N7O6S2 (519.0995)


   

n-(3-{[2-(2,4-dibromo-5-methoxyphenyl)ethyl](methyl)amino}propyl)-2-(dimethylamino)-4-methylpentanimidic acid

n-(3-{[2-(2,4-dibromo-5-methoxyphenyl)ethyl](methyl)amino}propyl)-2-(dimethylamino)-4-methylpentanimidic acid

C21H35Br2N3O2 (519.1096)


   

n-(3-{[2-(2,4-dibromo-5-methoxyphenyl)ethyl](methyl)amino}propyl)-2-(dimethylamino)-3-methylpentanimidic acid

n-(3-{[2-(2,4-dibromo-5-methoxyphenyl)ethyl](methyl)amino}propyl)-2-(dimethylamino)-3-methylpentanimidic acid

C21H35Br2N3O2 (519.1096)


   

3-{[(2s,3r,4s,5s,6r)-6-{[(2-carboxyacetyl)oxy]methyl}-3,4,5-trihydroxyoxan-2-yl]oxy}-5,7-dihydroxy-2-(4-hydroxyphenyl)-1λ⁴-chromen-1-ylium

3-{[(2s,3r,4s,5s,6r)-6-{[(2-carboxyacetyl)oxy]methyl}-3,4,5-trihydroxyoxan-2-yl]oxy}-5,7-dihydroxy-2-(4-hydroxyphenyl)-1λ⁴-chromen-1-ylium

[C24H23O13]+ (519.1139)


   

8-methoxy-6-nitro-10-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2h-phenanthro[3,4-d][1,3]dioxole-5-carboxylic acid

8-methoxy-6-nitro-10-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2h-phenanthro[3,4-d][1,3]dioxole-5-carboxylic acid

C23H21NO13 (519.1013)


   

(2s,3s)-n-(3-{[2-(2,4-dibromo-5-methoxyphenyl)ethyl](methyl)amino}propyl)-2-(dimethylamino)-3-methylpentanimidic acid

(2s,3s)-n-(3-{[2-(2,4-dibromo-5-methoxyphenyl)ethyl](methyl)amino}propyl)-2-(dimethylamino)-3-methylpentanimidic acid

C21H35Br2N3O2 (519.1096)